Patents by Inventor Andrzej Krolewski

Andrzej Krolewski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240110927
    Abstract: The invention provides methods (e.g., in vitro methods) for identifying subjects at risk of renal decline and/or progression to end stage renal disease (ESRD). Also included are diagnostic and prognostic tools using markers (e.g., protein biomarkers) that may be used to identify subjects who are at risk of developing ESRD.
    Type: Application
    Filed: February 2, 2023
    Publication date: April 4, 2024
    Inventor: Andrzej Krolewski
  • Patent number: 10953035
    Abstract: The invention provides methods for preventing end stage renal disease (ESRD) in subjects having a disorder associated with chronic kidney failure, such as diabetes or high blood pressure. Also included are markers (miRNAs) that may be used to identify subjects who are at risk of developing ESRD.
    Type: Grant
    Filed: October 26, 2018
    Date of Patent: March 23, 2021
    Inventors: Andrzej Krolewski, Marcus Pezzolesi
  • Publication number: 20190183919
    Abstract: The invention provides methods for preventing end stage renal disease (ESRD) in subjects having a disorder associated with chronic kidney failure, such as diabetes or high blood pressure. Also included are markers (miRNAs) that may be used to identify subjects who are at risk of developing ESRD.
    Type: Application
    Filed: October 26, 2018
    Publication date: June 20, 2019
    Inventors: Andrzej Krolewski, Marcus Pezzolesi
  • Publication number: 20060240437
    Abstract: The invention includes diagnostic, predictive, prognostic and monitoring methods and reagents for loss of renal function, e.g., diabetic nephropathy and end stage renal disease (ESRD).
    Type: Application
    Filed: June 4, 2004
    Publication date: October 26, 2006
    Inventors: Andrzej Krolewski, James Warram
  • Publication number: 20050142596
    Abstract: The present invention provides methods for predicting risk of developing renal disease or coronary artery disease in a subject, by evaluating expression, levels, or activity of p21, or the presence or absence of polymorphic variants thereof. Also described are methods of treating or preventing renal or coronary artery disease.
    Type: Application
    Filed: November 12, 2004
    Publication date: June 30, 2005
    Inventors: Andrzej Krolewski, Grzegorz Placha